HIV and overdoses: diversifying therapies for opioid use disorder - Authors' reply

Affiliations

¹ West Virginia Clinical and Translational Science Institute, University Health Sciences Center, West Virginia University, Morgantown, WV 26506, USA. Electronic address: slhodder@hsc.wvu.edu.
² West Virginia University School of Medicine, West Virginia University, Morgantown, WV 26506, USA.
³ University of California San Diego School of Medicine, La Jolla, CA, USA.
⁴ University of California Los Angeles, Los Angeles, CA, USA.
⁵ Yale University, New Haven, CT, USA.
⁶ Clarksburg Mission, Clarksburg, WV, USA.
⁷ Center for Public Health and Human Rights, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Comment

Sally L Hodder et al. Lancet. 2021.

. 2021 Aug 28;398(10302):742.

doi: 10.1016/S0140-6736(21)01221-6.

¹ West Virginia Clinical and Translational Science Institute, University Health Sciences Center, West Virginia University, Morgantown, WV 26506, USA. Electronic address: slhodder@hsc.wvu.edu.
² West Virginia University School of Medicine, West Virginia University, Morgantown, WV 26506, USA.
³ University of California San Diego School of Medicine, La Jolla, CA, USA.
⁴ University of California Los Angeles, Los Angeles, CA, USA.
⁵ Yale University, New Haven, CT, USA.
⁶ Clarksburg Mission, Clarksburg, WV, USA.
⁷ Center for Public Health and Human Rights, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

No abstract available

Conflict of interest statement

We declare no competing interests.

HIV and overdoses: diversifying therapies for opioid use disorder.
Waters RC, Oviedo-Joekes E, Rawlins J. Waters RC, et al. Lancet. 2021 Aug 28;398(10302):741-742. doi: 10.1016/S0140-6736(21)01251-4. Lancet. 2021. PMID: 34454662 No abstract available.